Click on a section name below to access the full editor list:

Basic and Translational Cancer Immunology Section

Section Editors

Claudia Palena, PhD
National Cancer Institute, National Institutes of Health – United States

Walter J. Storkus, PhD
University of Pittsburgh – United States

Eric Tartour, MD, PhD
Hôpital Européen Georges Pompidou – France

Deputy Editor

Associate Editors

Scott I. Abrams, PhD
Roswell Park Comprehensive Cancer Center – United States

Timothy NJ Bullock, PhD
University of Virginia – United States

Gennaro Ciliberto, MD
IRCCS Istituto Nazionale Tumori Regina Elena – Italy

Tanja D. de Gruijl, PhD
Amsterdam University Medical Centers – Netherlands

Jennifer L. Guerriero, PhD
Brigham and Women’s Hospital – United States

Pawel Kalinski, MD, PhD
Roswell Park Comprehensive Cancer Center – United States

Khashayarsha Khazaie, PhD, DSc
Mayo Clinic College of Medicine – United States

Sattva S. Neelapu, MD
The University of Texas MD Anderson Cancer Center – United States

Anna Obenauf, PhD
Research Institute of Molecular Pathology – Austria

Michael Platten, MD
Ruprecht-Karls University Heidelberg – Germany

Gabriel Rabinovich, PhD
Instituto de Biologia y Medicina Experimental (IByME) – Argentina

Alessandro Russo, MD, PhD
Università degli Studi di Messina – Italy

Stefani Spranger, PhD
Massachusetts Institute of Technology – United States 

Viktor Umansky, MD, PhD
German Cancer Research Center (DKFZ) – Germany

Louis M. Weiner, MD
Georgetown University Lombardi Cancer Center – United States

Case Reports Section

Section Editor

Sebastian Kobold, MD
Klinikum der Universität München – Germany

Associate Editors

Jack D. Bui, MD, PhD
University of California San Diego – United States

Marco Donia, MD, PhD
National Center for Cancer Immune Therapy (CCIT-DK) – Denmark

Heinz Läubli, MD, PhD
University Hospital Basel – Switzerland

Allison Betof Warner, MD, PhD
Stanford Cancer Center – United States

Clinical Cancer Immunotherapy Section

Section Editors

Jason J. Luke, MD, FACP
UPMC Hillman Cancer Center – United States

Douglas G. McNeel, MD, PhD
University of Wisconsin Carbone Cancer Center – United States

Associate Editors

Paulo Antonio Ascierto, MD
Istituto Nazional Tumori-Fondazione 'G.Pascale' – Italy

Tina Cascone, MD, PhD
The University of Texas MD Anderson Cancer Center – United States

Margaret E. Gatti-Mays, MD, MPH
Ohio State University Comprehensive Cancer Center – United States

Francois Ghiringhelli, PhD
Institut National De La Sante Et De Le Recherche Medicale (INSERM) – France

James J. Harding, MD
Memorial Sloan Kettering Cancer Center – United States

Douglas B. Johnson, MD, MSCI
Vanderbilt University Medical Center – United States

Yangqiu Li, MD
Jinan University School of Medicine – China

Ravi A. Madan, MD
National Cancer Institute, National Institutes of Health – United States

Luca Mazzarella, MD, PhD
European Institute of Oncology – Italy

Kunle Odunsi, MD, PhD
University of Chicago Medicine Comprehensive Cancer Center – United States

Ravi Patel, MD, PhD
University of Pittsburgh – United States

Commentary/Editorials Section

Section Editor

Christian Capitini, MD
University of Wisconsin, Madison – United States

Associate Editors

Ana Carrizosa Anderson, MD
Harvard University – United States

Diwakar Davar, MD
UPMC Hillman Cancer Center – United States

Michael Dougan, MD, PhD
Massachusetts General Hospital – United States

William J. Murphy, PhD
University of California, Davis – United States

Guidelines and Consensus Statements Section

Section Editor

Robert L. Ferris, MD, PhD
UNC Lineberger Comprehensive Cancer Center – United States

Immune Cell Therapies and Immune Cell Engineering Section

Section Editor

Aude Chapuis, MD
Fred Hutchinson Cancer Research Center – United States

Marcela V. Maus, MD, PhD
Massachusetts General Hospital – United States

Associate Editors

Marco L. Davila, MD, PhD
Roswell Park Comprehensive Cancer Center – United States

Joseph A. Fraietta, PhD
University of Pennsylvania – United States

Sara Ghorashian, MD, PhD
University College London – United Kingdom

Michael Hudecek, MD
Universitätsklinikum Würzburg – Germany

Michael D. Kalos, PhD
Next Pillar Consulting – United States

Gerald Linette, MD, PhD
University of Pennsylvania – United States

Daniel J. Powell Jr., PhD
University of Pennsylvania – United States

Marco Ruella, MD
University of Pennsylvania – United States

Lillian Seu, PhD
Revolution Medicines – United States

Nirali N. Shah, MD, MHSc
National Cancer Institute, National Institutes of Health – United States

Eric L. Smith, MD, PhD
Dana-Farber Cancer Institute – United States

Maria Themeli, MD, PhD
VUmc Cancer Center Amsterdam – Netherlands

Immunotherapy Biomarkers Section

Section Editors

Ignacio Melero, MD, PhD
Foundation for Applied Medical Research (FIMA) – Spain

Kurt A. Schalper, MD, PhD
Yale School of Medicine – United States

Alexandra Snyder Charen, MD
Generate Biomedicines – United States

Associate Editors

Maria Ascierto, PhD
University of Glasgow – United Kingdom

Carlo B. Bifulco, MD
Providence Portland Medical Center – United States

John C. Castle, PhD
Monte Rosa Therapeutics – Switzerland

Alessandra Cesano, MD, PhD
ESSA Pharma Inc. – United States

Carlos de Andrea, MD, PhD
University of Navarra– Spain

Eric Deutsch, MD, PhD
Gustave Roussy Cancer Campus – France

Elisabeth G.E. de Vries, MD, PhD
University Medical Centre Groningen – Netherlands

Jolanda de Vries, PhD
Radboud University Nijmegen – Netherlands

Rejean Lapointe, PhD
Universite De Montreal, University Hospital (CRCHUM) – Canada

Christian H. Ottensmeier, MD, PhD, FRCP
University of Southampton – United Kingdom

Graham P. Pawelec, PhD
University of Tuebingen – Germany

Licia Rivoltini, MD
Fondazione IRCCS Istituto Nazionale Tumori – Italy

Barbara Seliger, MD, PhD
Martin Luther University Halle-Wittenberg – Germany

Craig L. Slingluff Jr., MD
University of Virginia – United States

Claudio Tripodo, MD
University of Palermo – Italy

Jinada Yuan, MD, PhD
Merck & Co. – United States

Jon Zugazagoitia, MD, PhD
Hospital Gral 12 de Octubre – Spain

Oncolytic and Local Immunotherapy Section

Section Editor

Howard L. Kaufman, MD, FACS
Massachusetts General Hospital – United States

Associate Editors

Darrel J. Irvine, PhD
Massachusetts Institute of Technology – United States

Samuel Rabkin, PhD
Massachusetts General Hospital – United States

K. Dane Wittrup, PhD
Massachusetts Institute of Technology – United States

Dmitriy Zamarin, MD, PhD
Icahn School of Medicine at Mount Sinai – United States

Reviews Section

Section Editors

Sandra Demaria, MD
Weill Cornell Medical College – United States

Lawrence Fong, MD
Fred Hutchinson Cancer Center – United States

Associate Editors

Ira Mellman, PhD, FAACR, FAIO
Parker Institute for Cancer Immunotherapy, Medici Therapeutics – United States

James J. Mule, PhD
H. Lee Moffitt Cancer Center – United States

Specialty Editors

Consulting Editor, Special Series and Reviews

Pedro J. Romero, MD
Novigenix – Switzerland

Consulting Editor

Thomas F. Gajewski, MD, PhD
University of Chicago – United States

Social Media Editors

Kristin G. Anderson, PhD
University of Virginia – United States

Praveen Bommareddy, PhD, MS
Replimune, Inc. – United States

Cheng Sun, MD, PhD
University of Science and Technology of China, Hefei – China